Measurement of antibodies induced to patients with immunosuppressive state or chronic kidney disease by new influenza (A/H1N1) vaccination

Measurement of antibodies induced to patients with immunosuppressive state or chronic kidney disease by new influenza (A/H1N1) vaccination - Measurement of anti-new influenza (A/H1N1) antibody after vaccination

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002754

Enrollment

200

Registered

2009-11-11

Start date

2009-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

collagen-vascular diseases, rheumatoid arthritis and chronic kidney diseases

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Applicants of new influenza (A/H1N1)vaccination 2. Immunosuppressive state in patients with collagen-vascular diseases, rheumatoid arthritis, or chronic kidney diseases

Exclusion criteria

Exclusion criteria: 1. Patients with dementia 2. Patients considered inappropriate judged by attending physicians

Design outcomes

Primary

Measure	Time frame
Antibody prevalence of new influenza (A/H1N1) vaccine	—

Countries

Japan

Outcome results